Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer

PURPOSE: Adjuvant chemotherapy for breast cancer (BC) may be associated with increased rates of bone loss and decreased bone mineral density (BMD) and may lead to premature osteoporosis and increased fracture risk. We examined whether zoledronic acid (ZA) prevents bone loss in premenopausal women re...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hershman, Dawn L., McMahon, Donald J., Crew, Katherine D., Cremers, Serge, Irani, Dinaz, Cucchiara, Gina, Brafman, Lois, Shane, Elizabeth
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2008
Aiheet:
Breast Cancer
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2653138/
https://ncbi.nlm.nih.gov/pubmed/18711172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.16.4707
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia